The controversy erupted on June 26, 2024, when Elanco revealed that Zenrelia's label would include a boxed warning, highlighting safety issues identified during trials with unvaccinated dogs. The ...

Leerink analyst Daniel Clark initiated coverage of Elanco (ELAN) with a Market Perform rating and $14 price target The firm notes Elanco ...

We recently published a list of 12 Most Profitable Pharmaceutical Stocks Right Now. In this article, we are going to take a ...

Fintel reports that on December 2, 2024, Leerink Partners initiated coverage of Elanco Animal Health (NYSE:ELAN) with a ...

The Schall Law Firm Encourages Stockholder Participation In A Fraud Case Against Elanco Animal Health Incorporated ...

ELAN LEGAL DEADLINE: Elanco Animal Health Class Action Deadline Is Approaching – Contact BFA Law If You Suffered Losses (NYSE:ELAN) ...

In this settled action, In the Matter of Elanco Animal Health, Inc., Elanco, a manufacturer and seller of animal health products, such as flea ...

Elanco Animal Health Incorporated (NYSE: ELAN) today announced that management will participate in upcoming investor ...

In English language arts, the district is in the top 15% in the state. In fourth grade science, Elanco is in the top 3%; in ...

On Wednesday, Elanco Animal Health Inc (ELAN) stock saw a modest uptick, ending the day at $13.13 which represents no change from the prior close of of $13.13. The stock opened at $13.2 and touched a ...

Class Action Lawsuit Against Elanco Animal Health Incorporated (ELAN): The complaint alleges that the company minimized potential safety risks associated with Zenrelia, an oral Janus kinase ...

NEW YORK, Nov. 30, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE ...